Colin M. Coon

<i>MYCN</i> -Amplified Neuroblastoma Is Addicted to Iron and Vulnerable to Inhibition of the System Xc-/Glutathione Axis

Konstantinos V. Floros, Jinyang Cai, Sheeba Jacob et al. · Cancer Research · 2021 · 153 citations · Full text

Medicine, Oncology, Pharmacology +15

Increased Synthesis of MCL-1 Protein Underlies Initial Survival of <i>EGFR</i> -Mutant Lung Cancer to EGFR Inhibitors and Provides a Novel Drug Target

Kyung-A Song, Yasuyuki Hosono, Crystal Turner et al. · Clinical Cancer Research · 2018 · 66 citations

Medicine, Oncology, Pharmacology +17

The Ewing Family of Tumors Relies on BCL-2 and BCL-XL to Escape PARP Inhibitor Toxicity

Daniel A.R. Heisey, Timothy L. Lochmann, Konstantinos V. Floros et al. · Clinical Cancer Research · 2018 · 40 citations

Medicine, Oncology, Pharmacology +15

Venetoclax-based Rational Combinations are Effective in Models of <i>MYCN</i> -amplified Neuroblastoma

Krista M. Dalton, Kateryna Krytska, Timothy L. Lochmann et al. · Molecular Cancer Therapeutics · 2021 · 19 citations · Full text

Medicine, Oncology, Pharmacology +13

High-risk neuroblastoma with NF1 loss of function is targetable using SHP2 inhibition

Jinyang Cai, Sheeba Jacob, Richard Kurupi et al. · Cell Reports · 2022 · 18 citations · Full text

Medicine, Cancer Biology, Oncology +17